AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
The Business Research Company's Congestive Heart Failure (CHF) Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, February 20, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Is The Current And Projected Size Of The Congestive Heart Failure CHF Market?
The congestive heart failure CHF market continues to exhibit robust growth. According to the Congestive Heart Failure CHF Global Market Report 2025, this market which stood at $15.94 billion in 2024 is likely to grow to $17.10 billion in 2025 at a Compound Annual Growth Rate CAGR of 7.2%. This impressive growth over the historic period can be attributed to a number of factors such as the high prevalence of the aging population, an increase in cardiovascular diseases, greater awareness about heart health, rising healthcare expenditure, and growth in demand for remote patient monitoring.
Additionally, it is forecast that the CHF market size will continue to see strong growth over the next few years. It is projected to grow to $22.31 billion in 2029 at a compound annual growth rate CAGR of 6.9%. This buoyant forecast growth can be linked to rising adoption of digital health solutions, an increase in hypertension, increasing obesity rates, improving patient outcomes, and an increased focus on personalized medicine.
Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20730&type=smp
What Are The Key Drivers And Trends In The Congestive Heart Failure CHF Market?
The congestive heart failure CHF market continues to be driven by significant factors such as the increasing number of cardiovascular patients. Cardiovascular illnesses pertain to the heart and blood vessels, with emphasis on their critical role in circulating blood and maintaining overall health. The rise in cardiovascular patients can be attributed to sedentary lifestyles, unhealthy diets, ageing populations, and urbanization; factors that have necessitated advanced healthcare and treatment solutions.
CHF plays an instrumental role in providing targeted solutions that improve heart efficiency, reduce symptoms, and prevent complications for cardiovascular patients, thereby enhancing patient care and overall well-being. As highlighted by the American College of Cardiology, cardiovascular disease cases increased to 19.8 million in 2022, driving growth in the congestive heart failure CHF market. Eastern Europe recorded the highest mortality rate at 553 deaths per 100,000, which further underscores the market's growth.
Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-chf-global-market-report
Who Are The Leading Players In The Congestive Heart Failure CHF Market?
The CHF market is served by major companies such as Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG., Medtronic Plc, Eli Lilly and Company, Canon Medical Systems Corporation, Novo Nordisk A/S, Jarvik Heart Inc., Boston Scientific Corporation, Applied Molecular Genetics Inc., Biotronik SE & Co. KG, Exelixis Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., and LivaNova.
In the race for market dominance, these companies are committed to advanced innovations, such as single intracoronary infusion therapies, which offer effective treatment options that enhance heart function and quality of life for CHF patients. A popcorn case in point is Bayer AG’s partnership with Asklepios Biopharmaceutical to initiate the GenePHIT Phase II trial for AB-1002, an investigational gene therapy for CHF.
How Is The Congestive Heart Failure CHF Market Segmented?
1 By Type: Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure
2 By Treatment: Medication, Surgery
3 By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging MRI, Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis
4 By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5 By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings
What Is The Regional Scope Of The Congestive Heart Failure CHF Market?
In 2024, North America led the CHF market share and Asia Pacific is expected to be the fastest-growing region in the forecast period. The regional analysis of this market extends across Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Similar Reports By The Business Research Company:
Prosthetic Heart Valve Devices And Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report
Heart Attack Diagnostic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report
Implantable Heart Pacemaker Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report
About The Business Research Company
With over 15000+ reports covering 27 industries across 60+ geographies, The Business Research Company specializes in delivering comprehensive, data-rich research and unique insights. Leveraging 1,500,000 datasets, deep secondary research, and exclusive industry leader insights, you can secure the information you need to stay ahead.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
